E Head

First name:
E
Last name:
Head
Cenini, G., Dowling, A. L., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., et al. (2012). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica Et Biophysica Acta, 1822(2), 130-8. https://doi.org/10.1016/j.bbadis.2011.10.001
View
Lanzillotta, C., Zuliani, I., Tramutola, A., Barone, E., Blarzino, C., Caforio, M., et al. (2021). Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention. Progress In Neurobiology, 196, 101892. https://doi.org/10.1016/j.pneurobio.2020.101892
View
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020). Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiology Of Disease, 137, 104772. https://doi.org/10.1016/j.nbd.2020.104772
View
Tramutola, A., Di Domenico, F., Barone, E., Arena, A., Giorgi, A., di Francesco, L., et al. (2017). Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology. Antioxidants & Redox Signaling, 26(7), 280-298. https://doi.org/10.1089/ars.2016.6686 (Original work published 2017)
View
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., et al. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal Of Alzheimer's Disease : Jad, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)
View
Barone, E., Head, E., Butterfield, D. A., & Perluigi, M. (2017). HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology. Free Radical Biology & Medicine, 111, 262-269. https://doi.org/10.1016/j.freeradbiomed.2016.10.508
View
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Perluigi, M. (2018). Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism. Free Radical Biology & Medicine, 114, 84-93. https://doi.org/10.1016/j.freeradbiomed.2017.07.009
View
Di Domenico, F., Tramutola, A., Foppoli, C., Head, E., Perluigi, M., & Butterfield, D. A. (2018). mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia. Free Radical Biology & Medicine, 114, 94-101. https://doi.org/10.1016/j.freeradbiomed.2017.08.009
View
Opii, W. O., Joshi, G., Head, E., Milgram, N. W., Muggenburg, B. A., Klein, J. B., et al. (2008). Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiology Of Aging, 29(1), 51-70. https://doi.org/10.1016/j.neurobiolaging.2006.09.012
View
Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Murphy, M. P., Head, E., & Butterfield, D. A. (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal Of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x
View